Immune Health Supplements Market Size, Share & Trends Analysis Report By Product, By Form, By Application, By Mode Of Medication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Immune Health Supplements Market Size, Share & Trends Analysis Report By Product, By Form, By Application, By Mode Of Medication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030


Immune Health Supplements Market Growth & Trends

The global immune health supplements market size was estimated at USD 52.81 billion in 2030 and is projected to grow at a CAGR of 10.72% from 2024 to 2030. The growing prevalence of various infectious diseases caused by several micro-organisms, such as bacteria, fungi, viruses, and parasites, coupled with the rising demand for supplements to increase the body's immune system, is expected to boost the immune health supplements adoption across the globe. Besides, increasing adoption of immunity-boosting products due to the COVID-19 pandemic is also anticipated to accelerate the market growth over the forecast years. According to the Council for Responsible Nutrition (CRN) report in 2020, the consumption of dietary supplements among Americans was about 73 percent. However, taking dietary supplements among individuals for immune health has been increased from 27 percent to 32 percent from 2019 to 2020.

As of 2020, the vitamin and mineral supplements segment held the largest revenue share. The increasing adoption of vitamin C, D, multivitamins, and minerals resulted in a high revenue share for the segment in the market. An unhealthy diet limited physical activity, and a sedentary lifestyle are the key factors responsible for increasing vitamin and mineral intake to improve an individual's immunity, especially in the developed regions such as North America and Europe. However, the increasing patient population and growing awareness for vitamin and mineral consumption are the major factors expected to boost market growth in emerging economies such as Asia Pacific and Latin America during the forecast period. However, the herbal supplements segment is also anticipated to be the second-largest product segment due to its popularity for long-term consumption as immunity boosters without any side effects.

By form, the tablets segment accounted for the largest revenue share in 2020. Due to its longer shelf life and high preference of adoption among the individual's tablets segment is expected to be the dominated segment. Tablets are more stable than the capsule, particularly in moist environments. In addition, tablets are largely manufactured by the key market players than the other form of supplements. Further, properties of tablets such as durability, inexpensive, can be split into two parts, and higher dosage accommodation is anticipated its high adoption and maximum value share in the market.

The respiratory tract infection segment held the largest revenue share in 2020. Due to the increasing prevalence of respiratory disorders such as COPD, asthma, COVID19, immune health supplements adoption has increased in the last couple of years. Particularly, the rapid rise in life-threatening coronavirus disease from the last year has increased the adoption of immunity-boosting products to manage respiratory tract infections. Taking supplements such as Vitamin C, D, and minerals such as zinc and probiotics offers unique properties to reduce the risk of respiratory tract infection, duration, and severity of infection.

As of 2020, the self-medication segment accounted for the largest revenue share than the prescription-based segment. It can be attributed due to the high percentage of self-medicated supplements using the population around the globe. Further, most of the vitamins and mineral supplements do not require a prescription. One can purchase them from pharmacies, groceries, and any convenience stores. Besides, the growing awareness among the individuals to use immunity-boosting products due to COVID19 is also expected to provide a high market share to the self-medication segment over the forecast years globally.

The pharmacies/drug stores segment dominated the market and accounted for the largest revenue in 2020. The availability of a wide variety of products and the high preference of consumers to buy immune health supplements from pharmacies are the factors responsible for the largest market share of this segment. Moreover, the availability of both prescriptions based and over-the-counter products for the consumers is also expected to accelerate the growth of the Pharmacies/drug stores segment over the forecast years.

North America dominated the market and accounted for the largest revenue share in 2020. The increasing prevalence of various health disorders, increasing usage of immune-enhancing products, and high spending capacity by the consumers are the factors anticipated to provide the majority of market share to the region. However, Asia Pacific countries, such as China, India, and Japan, are expected to witness significant growth over the forecast years due to the large population, increasing awareness, and growing consumer base in these countries.

Immune Health Supplements Market Report Highlights
  • The market is expected to grow well over the forecast period owing to the increasing prevalence of several infectious diseases and growing awareness to improve immune health
  • The vitamin and mineral supplements segment dominated the market in 2020 owing to high demand and increasing use for immune health
  • The respiratory tract infection application segment dominated the market in 2020 owing to the increasing adoption of immune supplements to reduce the risk of respiratory tract infection across the globe
  • The self-medication segment dominated the market in 2020 majorly due to a growing preference for self-medicated use of supplements than prescription-based
  • The pharmacies/drug stores segment dominated the market in 2020 owing to the availability of a wide range of products and high consumer preference
  • North America dominated the market in 2020 majorly due to high spending capacity and increasing uses of immune health supplements in the region
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Formulation Segment
1.2.3. Source Type Segment
1.2.4. Mode of Medication Segment
1.2.5. Distribution Channel Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Immune Health Supplements Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing health consciousness
3.2.1.2. Rising prevalence of chronic diseases
3.2.1.3. Growing geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.3. Immune Health Supplements Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Immune Health Supplements Market: Product Estimates & Trend Analysis
4.1. Product Segment Dashboard
4.2. Global Immune Health Supplements Market Product Movement Analysis
4.3. Global Immune Health Supplements Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Vitamin & Mineral Supplements
4.4.1. Vitamin & mineral supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Vitamin C Supplements
4.4.2.1. Vitamin C supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Vitamin D Supplements
4.4.3.1. Vitamin D supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Vitamin B Complex Supplements
4.4.4.1. Vitamin B complex supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Multivitamins
4.4.5.1. Multivitamins market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Selenium Supplements
4.4.6.1. Selenium supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Zinc Supplements
4.4.7.1. Zinc supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Others
4.4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Amino Acids
4.5.1. Amino acids market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Omega-3 Fatty Acids
4.6.1. Omega-3 fatty acids market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Herbal Supplements
4.7.1. Herbal supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Probiotic Supplements
4.8.1. Probiotic supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Immune Health Supplements Market: Formulation Estimates & Trend Analysis
5.1. Formulation Segment Dashboard
5.2. Global Immune Health Supplements Market Formulation Movement Analysis
5.3. Global Immune Health Supplements Market Size & Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
5.4. Capsules
5.4.1. Capsules market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Tablets
5.5.1. Tablets market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Powder
5.6.1. Powder market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Liquid
5.7.1. Liquid market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Softgels
5.8.1. Softgels market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Immune Health Supplements Market: Source Type Estimates & Trend Analysis
6.1. Source Type Segment Dashboard
6.2. Global Immune Health Supplements Market Source Type Movement Analysis
6.3. Global Immune Health Supplements Market Size & Trend Analysis, by Source Type, 2018 to 2030 (USD Million)
6.4. Natural
6.4.1. Natural market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Synthetic
6.5.1. Synthetic market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Immune Health Supplements Market: Mode of Medication Estimates & Trend Analysis
7.1. Mode of Medication Segment Dashboard
7.2. Global Immune Health Supplements Market Mode of Medication Movement Analysis
7.3. Global Immune Health Supplements Market Size & Trend Analysis, by Mode of Medication, 2018 to 2030 (USD Million)
7.4. Prescription-based
7.4.1. Prescription-based market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Self-medication
7.5.1. Self-medication market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Immune Health Supplements Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Segment Dashboard
8.2. Global Immune Health Supplements Market Distribution Channel Movement Analysis
8.3. Global Immune Health Supplements Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
8.4. Offline
8.4.1. Offline market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Pharmacies & Drug Stores
8.4.2.1. Pharmacies & drug stores market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Hypermarkets/Supermarkets
8.4.3.1. Hypermarkets/supermarkets market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Others
8.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Online
8.5.1. Online market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Immune Health Supplements Market: Regional Estimates & Trend Analysis by Product, Formulation, Source Type, Mode of Medication, and Distribution Channel
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Competitive scenario
9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Europe
9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. France
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key country dynamics
9.5.7.2. Regulatory framework
9.5.7.3. Competitive scenario
9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.5.8. Sweden
9.5.8.1. Key country dynamics
9.5.8.2. Regulatory framework
9.5.8.3. Competitive scenario
9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.5.9. Denmark
9.5.9.1. Key country dynamics
9.5.9.2. Regulatory framework
9.5.9.3. Competitive scenario
9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. China
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. India
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Competitive scenario
9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Australia
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Competitive scenario
9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. South Korea
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework
9.6.6.3. Competitive scenario
9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework
9.6.7.3. Competitive scenario
9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework
9.7.2.3. Competitive scenario
9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework
9.7.3.3. Competitive scenario
9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.8. MEA
9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework
9.8.2.3. Competitive scenario
9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework
9.8.3.3. Competitive scenario
9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key country dynamics
9.8.4.2. Regulatory framework
9.8.4.3. Competitive scenario
9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key country dynamics
9.8.5.2. Regulatory framework
9.8.5.3. Competitive scenario
9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Nature's Way
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. NOW Foods
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Garden of Life
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Thorne Research
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Nordic Naturals
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Solaray
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Pure Encapsulations
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. The Nature's Bounty Co.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. MegaFood
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Jarrow Formulas
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Life Extension
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Product benchmarking
10.4.11.4. Strategic initiatives
10.4.12. Metagenics
10.4.12.1. Company overview
10.4.12.2. Financial performance
10.4.12.3. Product benchmarking
10.4.12.4. Strategic initiatives
10.4.13. Xymogen
10.4.13.1. Company overview
10.4.13.2. Financial performance
10.4.13.3. Product benchmarking
10.4.13.4. Strategic initiatives
10.4.14. Designs for Health
10.4.14.1. Company overview
10.4.14.2. Financial performance
10.4.14.3. Product benchmarking
10.4.14.4. Strategic initiatives
10.4.15. Douglas Laboratories
10.4.15.1. Company overview
10.4.15.2. Financial performance
10.4.15.3. Product benchmarking
10.4.15.4. Strategic initiatives
10.4.16. Bayer AG
10.4.16.1. Company overview
10.4.16.2. Financial performance
10.4.16.3. Product benchmarking
10.4.16.4. Strategic initiatives
10.4.17. Standard Process
10.4.17.1. Company overview
10.4.17.2. Financial performance
10.4.17.3. Product benchmarking
10.4.17.4. Strategic initiatives
10.4.18. Klaire Labs
10.4.18.1. Company overview
10.4.18.2. Financial performance
10.4.18.3. Product benchmarking
10.4.18.4. Strategic initiatives
10.4.19. Integrative Therapeutics
10.4.19.1. Company overview
10.4.19.2. Financial performance
10.4.19.3. Product benchmarking
10.4.19.4. Strategic initiatives
10.4.20. Amway, Co.
10.4.20.1. Company overview
10.4.20.2. Financial performance
10.4.20.3. Product benchmarking
10.4.20.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings